SHUSTERCAPITAL.COM
Shuster Capital | Life Science Business TransitionsLife Science Business Transitions. Emerging Rapid Growth—Turnarounds. Mr Lewis “Lew” Shuster is presently CEO of Shuster Capital, a strategic and operating advisor to life science company executives and investors with a focus on contract services, lab reagents and instruments, clinical diagnostics, and selected medical devices. To learn more, e-mail: info@Shustercapital.com. Start-ups: Retrotope (therapeutics), Sorrento Therapeutics (therapeutics), TissueNetix (reagents), Epitomics (reagents).
http://www.shustercapital.com/


